Microarray-based expression profiling studies of lung adenocarcinomas have defined neuroendocrine subclasses with poor prognosis. As neuroendocrine development is regulated by members of the achaetescute and atonal classes of basic helix-loop-helix (bHLH) transcription factors, we analyzed lung tumors for expression of these factors. Out of 13 bHLH genes tested, 4 genes, i.e., achaetescute complex-like 1 (ASCL1, HASH1, Mash1), atonal homolog 1 (ATOH1, HATH1, MATH1), NEUROD4 (ATH-3, Atoh3, MATH-3) and neurogenic differentiation factor 1 (NEUROD1, NEUROD, BE-TA2), showed differential expression among lung tumors and absent or low expression in normal lung. As expected, tumors that have high levels of ASCL1 also express neuroendocrine markers, and we found that this is accompanied by increased levels of NEUROD1. In addition, we found ATOH1 expression in 9 (16%) out of 56 analyzed adenocarcinomas and these tumors showed neuroendocrine features as shown by dopa decarboxylase mRNA expression and immunostaining for neuroendocrine markers. ATOH1 expression as well as NEUROD4 was observed in small cell lung carcinoma (SCLC), a known neuroendocrine tumor. Since ATOH1 is not known to be involved in normal lung development, our results suggest that aberrant activation of ATOH1 leads to a neuroendocrine phenotype similar to what is observed for ASCL1 activation during normal neuroendocrine development and in lung malignancies. Our preliminary data indicate that patients with ATOH1-expressing adenocarcinomas might have a worse prognosis.
FryW.A., PhillipsJ.L., MenckH.R.. Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report.Cancer1999; 86: 1867–76.
2.
BhattacharjeeA., RichardsW.G., StauntonJ.. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses.Proc Natl Acad Sci USA2001; 98: 13790–5.
3.
GarberM.E., TroyanskayaO.G., SchluensK.. Diversity of gene expression in adenocarcinoma of the lung.Proc Natl Acad Sci USA2001; 98: 13784–9.
4.
BeerD.G., KardiaS.L., HuangC.C.. Gene-expression profiles predict survival of patients with lung adenocarcinoma.Nat Med2002; 8: 816–24.
5.
VirtanenC., IshikawaY., HonjohD.. Integrated classification of lung tumors and cell lines by expression profiling.Proc Natl Acad Sci USA2002; 99: 12357–62.
6.
GiordanoT.J., SheddenK.A., SchwartzD.R.. Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles.Am J Pathol2001; 159: 1231–8.
7.
McDoniels-SilversA.L., NimriC.F., StonerG.D., LubetR.A., YouM.. Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas.Clin Cancer Res2002; 8: 1127–38.
8.
RoggliV.L., VollmerR.T., GreenbergS.D., McGavranM.H., SpjutH.J., YesnerR.. Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases.Hum Pathol1985; 16: 569–79.
9.
HiroshimaK., IyodaA., ShibuyaK.. Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung.Ann Thorac Surg2002; 73: 1732–5.
10.
BerendsenH.H., de LeijL., PoppemaS., PostmusP.E., BoesA., SluiterH.J., TheH.. Clinical characterization of non-small-cell lung cancer tumors showing neuroendocrine differentiation features.J Clin Oncol1989; 7: 1614–20.
11.
BorgesM., LinnoilaR.I., van de VeldeH.J.. An achaetescute homologue essential for neuroendocrine differentiation in the lung.Nature1997; 386: 852–5.
12.
ItoT., UdakaN., YazawaT.. Basic helix-loop-helix transcription factors regulate the neuroendocrine differentiation of fetal mouse pulmonary epithelium.Development2002; 127: 3913–21.
13.
BallD.W., AzzoliC.G., BaylinS.B.. Identification of a human achaetescute homolog highly expressed in neuroendocrine tumors.Proc Natl Acad Sci U S A,1993; 90: 5648–52.
14.
ChenH., BielM.A., BorgesM.W.. Tissue-specific expression of human achaetescute homologue-1 in neuroendocrine tumors: transcriptional regulation by dual inhibitory regions.Cell Growth Differ1997; 8: 677–86.
15.
WestermanB.A., NeijenhuisS., PoutsmaA.. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.Clin Cancer Res2002; 8: 1082–6.
16.
SoderholmH., OrtoftE., JohanssonI.. Human achaetescute homologue 1 (HASH-1) is downregulated in differentiating neuroblastoma cells.Biochem Biophys Res Commun1999; 256: 557–63.
17.
MountainC.F.. Revisions in the International System for Staging Lung Cancer.Chest1997; 111: 1710–7.
18.
WestermanB.A., PoutsmaA., MaruyamaK., SchrijnemakersH.F., van WijkI.J., OudejansC.B.. The proneural genes NEU-ROD1 and NEUROD2 are expressed during human trophoblast invasion.Mech Dev2002; 113: 85–90.
19.
ChretienS., DubartA., BeaupainD.. Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression.Proc Natl Acad Sci U S A1988; 85: 6–10.
20.
WestermanB.A., PoutsmaA., LooijengaL.H., WoutersD., van WijkI.J., OudejansC.B.. The Human Achaete Scute Homolog 2 gene contains two promotors, generating overlapping transcripts and encoding two proteins with different nuclear localization.Placenta2001; 6: 511–8.
21.
DrivsholmL., PaloheimoL.I., OsterlindK.. Chromogranin A, a significant prognostic factor in small cell lung cancer.Br J Cancer1999; 81: 667–71.
22.
LeonardJ.H., CookA.L., Van GeleM.. Proneural and proneuroendocrine transcription factor expression in cutaneous mechanoreceptor (Merkel) cells and Merkel cell carcinoma.Int J Cancer2002; 101: 103–10.
23.
YangQ., BerminghamN.A., FinegoldM.J., ZoghbiH.Y.. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine.Science2001; 294: 2155–8.
24.
BerminghamN.A., HassanB.A., PriceS.D.. Math1: an essential gene for the generation of inner ear hair cells.Science284: 1837–41.
25.
Ben-ArieN., BellenH.J., ArmstrongD.L.. Math1 is essential for genesis of cerebellar granule neurons.Nature1997; 390: 169–72.
26.
LeeY., MillerH.L., JensenP.. A molecular fingerprint for medulloblastoma.Cancer Res; 63: 5428–37.
27.
LeowC.C., RomeroM.S., RossS., PolakisP., GaoW.Q.. Hath1, down-regulated in colon adenocarcinomas, inhibits proliferation and tumorigenesis of colon cancer cells.Cancer Res2004; 64: 6050–7.
28.
NoloR., AbbottL.A., BellenH.J.. Senseless, a Zn finger transcription factor, is necessary and sufficient for sensory organ development in Drosophila.Cell2000; 102: 349–62.
29.
KazanjianA., WallisD., AuN.. Growth factor independence-1 is expressed in primary human neuroendocrine lung carcinomas and mediates the differentiation of murine pulmonary neuroendocrine cells.Cancer Res2004; 64: 6874–82.
30.
WatkinsD.N., BermanD.M., BurkholderS.G., WangB., BeachyP.A., BaylinS.B.. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer.Nature2003; 422: 313–7.
31.
InoueT., HojoM., BesshoY., TanoY., LeeJ.E., KageyamaR.. Math3 and NeuroD regulate amacrine cell fate specification in the retina.Development2002; 129: 831–42.
32.
OhsawaR., OhtsukaT., KageyamaR.. Mash1 and Math3 are required for development of branchiomotor neurons and maintenance of neural progenitors.J Neurosci2005; 25: 5857–65.
33.
LinnoilaR.I., ZhaoB., DeMayoJ.L.. Constitutive achaetescute homologue-1 promotes airway dysplasia and lung neuroendocrine tumors in transgenic mice.Cancer Res2000; 60: 4005–9.
34.
NayaF.J., HuangH.P., QiuY.. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice.Genes Dev1997; 11: 2323–34.
35.
HuY., IppolitoJ.E., GarabedianE.M., HumphreyP.A., GordonJ.I.. Molecular characterization of a metastatic neuroendocrine cell cancer arising in the prostates of transgenic mice.J Biol Chem2002; 277: 44462–74.
36.
GradwohlG., DierichA., LeMeurM., GuillemotF.. Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas.Proc Natl Acad Sci U S A2000; 97: 1607–11.
37.
JennyM., UhlC., RocheC.. Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium.EMBO J2002; 21: 6338–47.
